An Argus II Case Report
The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, USA) is the first US Food and Drug Administration-approved retinal implant. It provides electrical stimulation of the retina and induces visual perception in individuals with low vision. It is used in patients w...
Main Authors: | İrfan Perente, Gürkan Erdoğan, Muhittin Taşkapılı |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2017-05-01
|
Series: | Beyoglu Eye Journal |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-54264 |
Similar Items
-
Long-term visual outcomes and rehabilitation in Usher syndrome type II after retinal implant Argus II
by: Jeroni Nadal, et al.
Published: (2018-08-01) -
Safety, effectiveness, and cost-effectiveness of Argus II in patients with retinitis pigmentosa: a systematic review
by: Zakieh Ostad-Ahmadi, et al.
Published: (2021-02-01) -
The Argus-II Retinal Prosthesis Implantation; From the Global to Local Successful Experience
by: Mohsen Farvardin, et al.
Published: (2018-09-01) -
Endoscope-Assisted and Controlled Argus II Epiretinal Prosthesis Implantation in Late-Stage Retinitis Pigmentosa: A Report of 2 Cases
by: Emin Özmert, et al.
Published: (2016-12-01) -
A Patient-Specific Computational Framework for the Argus II Implant
by: Kathleen E. Finn, et al.
Published: (2020-01-01)